Pfizer Inc.
PFE
$25.42
-$0.27-1.05%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2023 | 10/01/2023 | 07/02/2023 | 04/02/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -167.46% | -- | -76.51% | -29.51% | 47.19% |
| Total Depreciation and Amortization | 10.70% | -- | 34.13% | 24.70% | 13.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -319.78% | -- | -760.14% | 83.46% | 51.49% |
| Change in Net Operating Assets | 246.03% | -- | -41.58% | -654.38% | 26.07% |
| Cash from Operations | -38.94% | -- | -114.79% | -81.47% | 45.11% |
| Capital Expenditure | -4.30% | -- | -21.70% | -77.14% | 0.10% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -158.79% | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 150.34% | -- | -132.40% | -40.09% | 943.62% |
| Cash from Investing | -149.34% | -- | -125.27% | 484.66% | -70.53% |
| Total Debt Issued | 985.91% | -- | 597.56% | -- | -226.79% |
| Total Debt Repaid | 105.39% | -- | -554.55% | 85.29% | -74.04% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.12% | -- | -3.16% | -2.40% | -2.56% |
| Other Financing Activities | -357.14% | -- | -192.16% | 12.80% | -96.52% |
| Cash from Financing | 208.51% | -- | 978.33% | 57.87% | -49.66% |
| Foreign Exchange rate Adjustments | 96.15% | -- | 92.42% | -100.00% | 3.70% |
| Miscellaneous Cash Flow Adjustments | -100.00% | -- | -200.00% | -- | -- |
| Net Change in Cash | 63.56% | -- | 169.04% | 231.57% | -1,640.00% |
